Literature DB >> 10733050

Coronary artery calcification in older adults with minimal clinical or subclinical cardiovascular disease.

A B Newman1, B Naydeck, K Sutton-Tyrrell, D Edmundowicz, J Gottdiener, L H Kuller.   

Abstract

BACKGROUND: Coronary artery calcification (CAC) reflects the extent of coronary artery atherosclerosis. The extent of coronary artery calcification is not well described in older adults.
OBJECTIVE: To determine the extent of CAC in older adults participating in a large population study of cardiovascular disease (CVD), especially those characterized as having minimal clinical or subclinical cardiovascular disease.
DESIGN: An observational epidemiologic study. POPULATION: Participants in the Cardiovascular Health Study Cohort, mean age 78 years, who had electron beam computed tomography (EBT) scan of the heart (n = 133); included were 106 persons with no prior evidence of clinical or subclinical CVD. MEASUREMENTS: Total CAC score was measured using cardiac EBT. Cardiovascular disease and risk factors, as well as carotid ultrasound, electrocardiogram, echocardiogram, and ankle-arm index, had been measured previously to define subclinical disease. Previous cerebral magnetic resonance imaging was also evaluated.
RESULTS: Overall, the CAC scores were higher in those with clinical cardiovascular disease or evidence of subclinical cardiovascular disease than in those with no evidence of disease. For the 106 participants without evidence of clinical or subclinical disease, the median score was 176, compared with 367 in those with subclinical disease and 923 in those with clinical CVD. Seventeen persons had scores of zero. There was little difference in risk factors across quartiles of CAC in the subgroup of 106 with prior characterization of minimal CVD despite the broad range of CAC scores. There was a higher proportion of those with white matter grade > or = 2 by magnetic resonance imaging among those with higher CAC scores (P = .025). Infarct-like lesions prevalence ranged from 12.5% in the lowest group to 47.1% in the highest CAC group (P = .019).
CONCLUSIONS: Older adults with evidence of clinical or subclinical CVD have higher total CAC scores. Though the extent of coronary artery calcification was lower in those with minimal evidence of CVD, the range was broad and not explained by CVD risk factors.

Entities:  

Mesh:

Year:  2000        PMID: 10733050     DOI: 10.1111/j.1532-5415.2000.tb02643.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  7 in total

1.  Absence of left ventricular concentric hypertrophy: a prerequisite for zero coronary calcium score.

Authors:  Shoichi Ehara; Nobuyuki Shirai; Takuhiro Okuyama; Kenji Matsumoto; Yoshiki Matsumura; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2010-12-23       Impact factor: 2.037

Review 2.  Emerging, noninvasive surrogate markers of atherosclerosis.

Authors:  Samir N Patel; Venkataraman Rajaram; Sanjay Pandya; Benjamin M Fiedler; Charlotte J Bai; Rachel Neems; Matt Feinstein; Marshall Goldin; Steven B Feinstein
Journal:  Curr Atheroscler Rep       Date:  2004-01       Impact factor: 5.113

3.  Susceptibility Loci for Clinical Coronary Artery Disease and Subclinical Coronary Atherosclerosis Throughout the Life-Course.

Authors:  Elias Salfati; Shuktika Nandkeolyar; Stephen P Fortmann; Stephen Sidney; Mark A Hlatky; Thomas Quertermous; Alan S Go; Carlos Iribarren; David M Herrington; Benjamin A Goldstein; Themistocles L Assimes
Journal:  Circ Cardiovasc Genet       Date:  2015-09-28

4.  Coronary artery calcium and physical function in older adults: the Cardiovascular Health Study.

Authors:  Marco Inzitari; Barbara L Naydeck; Anne B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-10       Impact factor: 6.053

5.  C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis.

Authors:  Amy H Kao; Mary Chester M Wasko; Shanthi Krishnaswami; Joseph Wagner; Daniel Edmundowicz; Penny Shaw; Amy Lynn Cunningham; Natalya Danchenko; Kim Sutton-Tyrrell; Russell P Tracy; Lewis H Kuller; Susan Manzi
Journal:  Am J Cardiol       Date:  2008-06-26       Impact factor: 2.778

6.  Fetuin-A and risk of coronary heart disease: A Mendelian randomization analysis and a pooled analysis of AHSG genetic variants in 7 prospective studies.

Authors:  Lars E Laugsand; Joachim H Ix; Traci M Bartz; Luc Djousse; Jorge R Kizer; Russell P Tracy; Abbas Dehghan; Kathryn Rexrode; Oscar L Lopez; Eric B Rimm; David S Siscovick; Christopher J O'Donnell; Anne Newman; Kenneth J Mukamal; Majken K Jensen
Journal:  Atherosclerosis       Date:  2015-09-05       Impact factor: 5.162

7.  Real-World Experience With a Tapered Biodegradable Polymer-Coated Sirolimus-Eluting Stent in Patients With Long Coronary Artery Stenoses.

Authors:  Alessandro Lupi; Fabrizio Ugo; Leonardo De Martino; Vincenzo Infantino; Mario Iannaccone; Sergio Iorio; Angelo Di Leo; Salvatore Colangelo; Marco Zanera; Alon Schaffer; Simone Persampieri; Roberto Garbo; Gaetano Senatore
Journal:  Cardiol Res       Date:  2020-06-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.